PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • His current principal focus as a member of Sughrue's Pharma Litigation Group is Hatch-Waxman Act ANDA litigation involving such blockbuster drugs as Lipitor??, Cymbalta??, Lyrica??, and Zithromax??.
http://www.w3.org/ns/prov#wasQuotedFrom
  • sughrue.com